IP Library Granted Patent US 11,628,054
Granted Patent B2
US 11,628,054 · App. 16/921,428 · Granted Apr 18, 2023

Surgical attachment device

Inventors: E. Skott Greenhalgh (Gladwyne, PA); John-Paul Romano (Chalfont, PA)
Assignee: Tela Bio, Inc
A61F2/0063A61F2/12A61L27/24A61L31/005A61L31/14A61F2/0059A61F2002/0068A61F2210/0004A61F2210/0076A61F2220/0075A61F2230/0008A61F2240/001A61F2250/003A61F2250/0003A61F2250/0017A61F2250/0018A61F2250/0023A61F2250/0028A61F2250/0029A61F2250/0031A61F2250/0078A61L2430/04Y10T29/49947
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,628,054
App. No.
16/921,428
Granted
Apr 18, 2023
Kind
B2
Abstract

A hybrid medical device that can aid in reconstructive or augmentative surgery of the breast is disclosed. The device can utilize a suitable biological collagen tissue matrix combined with a synthetic material, for example, that can impart a high initial strength to the repair site while permitting proper healing and revitalization of the implanted device.

Claims (52)

1. An implantable support device comprising:

a scaffold having a first end, a second end, a first edge, and a second edge, wherein the first edge and the second edge extend between the first end and the second end;

a first leader, wherein the first leader has a first section and a second section that extend between the first and second ends, wherein the first leader has a first apex and a second apex, and wherein the first and second apexes are farther apart than the first and second sections; and

a second leader, wherein the second leader extends from the first edge to the second edge, and wherein the second leader extends over the first and second sections.

2. The implantable support device of claim 1 , wherein the first leader has a third apex, and wherein the third apex is opposite the first and second apexes.

3. The implantable support device of claim 1 , wherein the first edge is farther from the second edge at a longitudinal center of the scaffold than at the first and second ends.

4. The implantable support device of claim 3 , wherein the first edge is convex and/or wherein the second edge is convex.

5. The implantable support device of claim 1 , wherein the first and second sections are separated by a first gap at a longitudinal center of the scaffold and by a second gap at the first and second ends, and wherein the first gap is wider than the second gap.

6. The implantable support device of claim 1 , wherein the scaffold comprises holes, apertures, slits, and/or pores, and wherein tissue and/or fluid is passable through the holes, apertures, slits, and/or pores.

7. The implantable support device of claim 6 , wherein the holes, apertures, slits, and/or pores are aligned or offset through adjacent layers of the scaffold.

8. The implantable support device of claim 1 , wherein the first leader is configured to strain and deliver a resistive force through the implantable support device.

9. An implantable support device comprising:

a scaffold having a first end, a second end, a first edge, and a second edge, wherein the first edge and the second edge extend between the first end and the second end;

a first leader, wherein the first leader has a first section and a second section that extend between the first and second ends, wherein the first leader is configured to deliver a resistive force through the implantable support device; and

a second leader, wherein the second leader extends from the first edge to the second edge, and wherein the second leader extends over the first leader.

10. The implantable support device of claim 9 , wherein the first leader has a first apex and a second apex, and wherein the first and second apexes are farther apart than the first and second sections.

11. The implantable support device of claim 9 , wherein the scaffold comprises a channel from a first external side of the scaffold to a second external side of the scaffold, wherein the first external side of the scaffold is opposite the second external side, and wherein tissue is growable in the channel and/or fluid is flowable through the channel.

12. The implantable support device of claim 11 , wherein the channel is a tortious path or an incomplete path between the external first and second external sides of the scaffold.

13. An implantable support device comprising:

a scaffold having a first end, a second end, a first edge, and a second edge, wherein the first edge and the second edge extend between the first end and the second end; and

a first leader, wherein the first leader has a first section and a second section that extend between the first and second ends, wherein the first and second sections are inside the scaffold from the first end to the second end, and wherein the first leader has a first apex and a second apex, and wherein the first apex is opposite the second apex.

14. The implantable support device of claim 13 , further comprising a second leader, wherein the second leader extends from the first edge to the second edge, and wherein the second leader extends over the first leader.

15. The implantable support device of claim 13 , wherein the scaffold comprises channels, and wherein tissue is growable in the channels and/or fluid is flowable through the channels.

16. The implantable support device of claim 13 , wherein the first leader is configured to deliver a resistive force through the implantable support device.

17. An implantable support device comprising:

a scaffold having a first end, a second end, a first edge, and a second edge, wherein the first edge and the second edge extend between the first end and the second end; and

a first leader, wherein the first leader has a first section and a second section that extend between the first and second ends, wherein the first leader has a first apex and a second apex, and wherein the first and second apexes are farther apart than the first and second sections,

wherein the scaffold comprises holes, apertures, slits, and/or pores, and wherein tissue and/or fluid is passable through the holes, apertures, slits, and/or pores, and

wherein the holes, apertures, slits, and/or pores are aligned or offset through adjacent layers of the scaffold.

18. The implantable support device of claim 17 , wherein the first leader has a third apex, and wherein the third apex is opposite the first and second apexes.

19. The implantable support device of claim 17 , wherein the first edge is farther from the second edge at a longitudinal center of the scaffold than at the first and second ends.

20. The implantable support device of claim 19 , wherein the first edge is convex and/or wherein the second edge is convex.

21. The implantable support device of claim 17 , wherein the first and second sections are separated by a first gap at a longitudinal center of the scaffold and by a second gap at the first and second ends, and wherein the first gap is wider than the second gap.

22. The implantable support device of claim 17 , wherein the first leader is configured to strain and deliver a resistive force through the implantable support device.

23. An implantable support device comprising:

a scaffold having a first end, a second end, a first edge, and a second edge, wherein the first edge and the second edge extend between the first end and the second end; and

a first leader, wherein the first leader has a first section and a second section that extend between the first and second ends, wherein the first leader is configured to deliver a resistive force through the implantable support device,

wherein the scaffold comprises a channel from a first external side of the scaffold to a second external side of the scaffold, wherein the first external side of the scaffold is opposite the second external side, and wherein tissue is growable in the channel and/or fluid is flowable through the channel.

24. The implantable support device of claim 23 , wherein the first leader has a first apex and a second apex, and wherein the first and second apexes are farther apart than the first and second sections.

25. The implantable support device of claim 23 , wherein the channel is a tortious path or an incomplete path between the external first and second external sides of the scaffold.

26. An implantable support device comprising:

a scaffold having a first end, a second end, a first edge, and a second edge, wherein the first edge and the second edge extend between the first end and the second end;

a first leader, wherein the first leader has a first section and a second section that extend between the first and second ends, and wherein the first and second sections are inside the scaffold from the first end to the second end; and

a second leader, wherein the second leader extends from the first edge to the second edge, and wherein the second leader extends over the first leader.

27. The implantable support device of claim 26 , wherein the first leader has a first apex and a second apex, and wherein the first apex is adjacent the second apex.

28. The implantable support device of claim 26 , wherein the scaffold comprises channels, and wherein tissue is growable in the channels and/or fluid is flowable through the channels.

29. The implantable support device of claim 26 , wherein the first leader is configured to deliver a resistive force through the implantable support device.

30. An implantable support device comprising:

a scaffold having a first end, a second end, a first edge, and a second edge, wherein the first edge and the second edge extend between the first end and the second end; and

a first leader, wherein the first leader has a first section and a second section that extend between the first and second ends, and wherein the first and second sections are inside the scaffold from the first end to the second end,

wherein the scaffold comprises channels, and wherein tissue is growable in the channels and/or fluid is flowable through the channels.

31. The implantable support device of claim 30 , wherein the first leader is configured to deliver a resistive force through the implantable support device.

Assignments (4)
SECURITY INTEREST Recorded Nov 14, 2025
From: TELA BIO, INC.
To: PERCEPTIVE CREDIT HOLDINGS V, LP, AS ADMINISTRATIVE AGENT
Reel/Frame 072905/0537 →
RELEASE OF SECURITY INTEREST Recorded Nov 14, 2025
From: MIDCAP FINANCIAL TRUST
To: TELA BIO, INC.
Reel/Frame 072912/0103 →
SECURITY INTEREST Recorded Aug 24, 2022
From: TELA BIO, INC.
To: MIDCAP FINANCIAL TRUST
Reel/Frame 060888/0633 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 6, 2020
From: GREENHALGH, E. SKOTT; ROMANO, JOHN-PAUL
To: TELA BIO, INC.
Reel/Frame 053127/0699 →
Cited By (4)
US 12,208,000 US 12,318,275 US 12,419,996 US 12,508,116